Severe Hypocalcemia due to Denosumab in Metastatic Prostate Cancer

Denosumab is a monoclonal antibody used for prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors. Hypocalcemia is a rare and dangerous side effect of the drug Denosumab. We present a case of a patient with metastatic prostate cancer who developed severe hyp...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Muqeet Adnan, Mohammed, Bhutta, Usman, Iqbal, Tanzeel, AbdulMujeeb, Sufyan, Haragsim, Lukas, Amer, Syed
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2014
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4099037/
https://ncbi.nlm.nih.gov/pubmed/25054070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/565393
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak